Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-10-26

FDA Approved: EVAMIST — Supplemental Application (Padagis US LLC)

View source ↗

Summary

The FDA approved a supplemental application for EVAMIST (estradiol) submitted by Padagis US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EVAMIST (ESTRADIOL)

Snippet

SUPPL AP for EVAMIST (ESTRADIOL)